1. Home
  2. ZGM vs CLGN Comparison

ZGM vs CLGN Comparison

Compare ZGM & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZGM

Zenta Group Company Limited Ordinary Shares

N/A

Current Price

$1.65

Market Cap

18.3M

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.33

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZGM
CLGN
Founded
2019
2004
Country
Macau
Israel
Employees
9
N/A
Industry
Professional Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
18.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ZGM
CLGN
Price
$1.65
$0.33
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
10.3K
60.4K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
$20.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.32
52 Week High
$4.44
$4.98

Technical Indicators

Market Signals
Indicator
ZGM
CLGN
Relative Strength Index (RSI) 51.33 27.29
Support Level $1.38 N/A
Resistance Level $1.87 $0.73
Average True Range (ATR) 0.17 0.10
MACD 0.02 -0.01
Stochastic Oscillator 71.79 1.18

Price Performance

Historical Comparison
ZGM
CLGN

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: